These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 28127851)

  • 21. Postprandial serum C-peptide to plasma glucose concentration ratio correlates with oral glucose tolerance test- and glucose clamp-based disposition indexes.
    Okuno Y; Komada H; Sakaguchi K; Nakamura T; Hashimoto N; Hirota Y; Ogawa W; Seino S
    Metabolism; 2013 Oct; 62(10):1470-6. PubMed ID: 23831440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. One-Hour Postload Hyperglycemia Is a Stronger Predictor of Type 2 Diabetes Than Impaired Fasting Glucose.
    Fiorentino TV; Marini MA; Andreozzi F; Arturi F; Succurro E; Perticone M; Sciacqua A; Hribal ML; Perticone F; Sesti G
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3744-51. PubMed ID: 26274345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations Between Serum 25-Hydroxyvitamin D, Insulin Sensitivity, Insulin Secretion, and β-Cell Function According to Glucose Tolerance Status.
    Morisset AS; Tardio V; Weisnagel J; Lemieux S; Bergeron J; Gagnon C
    Metab Syndr Relat Disord; 2015 Jun; 13(5):208-13. PubMed ID: 25781493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of a combination of oral anti-diabetes drugs with basal insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes.
    Mu PW; Chen YM; Lu HY; Wen XQ; Zhang YH; Xie RY; Shu J; Wang MM; Zeng LY
    Diabetes Metab Res Rev; 2012 Mar; 28(3):236-40. PubMed ID: 21898754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved meal-related insulin processing contributes to the enhancement of B-cell function by the DPP-4 inhibitor vildagliptin in patients with type 2 diabetes.
    Ahrén B; Pacini G; Tura A; Foley JE; Schweizer A
    Horm Metab Res; 2007 Nov; 39(11):826-9. PubMed ID: 17992639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin Secretion Predicts the Response to Antidiabetic Therapy in Patients With New-onset Diabetes.
    Abdelgani S; Puckett C; Adams J; Triplitt C; DeFronzo RA; Abdul-Ghani M
    J Clin Endocrinol Metab; 2021 Nov; 106(12):3497-3504. PubMed ID: 34343296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular safety of combination therapies with incretin-based drugs and metformin compared with a combination of metformin and sulphonylurea in type 2 diabetes mellitus--a retrospective nationwide study.
    Mogensen UM; Andersson C; Fosbøl EL; Schramm TK; Vaag A; Scheller NM; Torp-Pedersen C; Gislason G; Køber L
    Diabetes Obes Metab; 2014 Oct; 16(10):1001-8. PubMed ID: 24827939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The beneficial effect of metformin on β-cell function in non-obese Chinese subjects with newly diagnosed type 2 diabetes.
    Bi Y; Tong GY; Yang HJ; Cai MY; Ma JH; Liang J; Xin B; Miao H; Peng ZH; Zhu DL
    Diabetes Metab Res Rev; 2013 Nov; 29(8):664-72. PubMed ID: 23955995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Role of standard test meal in initiation of insulin therapy in type 2 diabetes].
    Koprivica B; Beljić-Zivković T; Ille T
    Srp Arh Celok Lek; 2009; 137(9-10):490-6. PubMed ID: 19950754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fasting serum total bile acid levels are associated with insulin sensitivity, islet β-cell function and glucagon levels in response to glucose challenge in patients with type 2 diabetes.
    Wang XH; Xu F; Cheng M; Wang X; Zhang DM; Zhao LH; Cai HL; Huang HY; Chen T; Zhang XL; Wang XQ; Cheng XB; Su JB; Lu Y
    Endocr J; 2020 Nov; 67(11):1107-1117. PubMed ID: 32684527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Teneligliptin improves glycemic control with the reduction of postprandial insulin requirement in Japanese diabetic patients.
    Tsuchimochi W; Ueno H; Yamashita E; Tsubouchi C; Sakoda H; Nakamura S; Nakazato M
    Endocr J; 2015; 62(1):13-20. PubMed ID: 25252844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired beta cell glucose sensitivity rather than inadequate compensation for insulin resistance is the dominant defect in glucose intolerance.
    Mari A; Tura A; Natali A; Laville M; Laakso M; Gabriel R; Beck-Nielsen H; Ferrannini E;
    Diabetologia; 2010 Apr; 53(4):749-56. PubMed ID: 20225397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of sitagliptin on circulating zinc-α2-glycoprotein levels in newly diagnosed type 2 diabetes patients: a randomized trial.
    Tian M; Liang Z; Liu R; Li K; Tan X; Luo Y; Yang M; Gu HF; Liu H; Li L; Yang G
    Eur J Endocrinol; 2016 Feb; 174(2):147-55. PubMed ID: 26546612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liraglutide suppresses non-esterified free fatty acids and soluble vascular cell adhesion molecule-1 compared with metformin in patients with recent-onset type 2 diabetes.
    Chen XM; Zhang WQ; Tian Y; Wang LF; Chen CC; Qiu CM
    Cardiovasc Diabetol; 2018 Apr; 17(1):53. PubMed ID: 29636047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin.
    Kitabchi AE; Temprosa M; Knowler WC; Kahn SE; Fowler SE; Haffner SM; Andres R; Saudek C; Edelstein SL; Arakaki R; Murphy MB; Shamoon H;
    Diabetes; 2005 Aug; 54(8):2404-14. PubMed ID: 16046308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imeglimin increases glucose-dependent insulin secretion and improves β-cell function in patients with type 2 diabetes.
    Pacini G; Mari A; Fouqueray P; Bolze S; Roden M
    Diabetes Obes Metab; 2015 Jun; 17(6):541-545. PubMed ID: 25694060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Teneligliptin, a Dipeptidyl Peptidase-4 Inhibitor, Improves Early-Phase Insulin Secretion in Drug-Naïve Patients with Type 2 Diabetes.
    Ito R; Fukui T; Hayashi T; Osamura A; Ohara M; Hara N; Higuchi A; Yamamoto T; Hirano T
    Drugs R D; 2015 Sep; 15(3):245-51. PubMed ID: 26224337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A variant of the glucose transporter gene SLC2A2 modifies the glycaemic response to metformin therapy in recently diagnosed type 2 diabetes.
    Rathmann W; Strassburger K; Bongaerts B; Kuss O; Müssig K; Burkart V; Szendroedi J; Kotzka J; Knebel B; Al-Hasani H; Roden M;
    Diabetologia; 2019 Feb; 62(2):286-291. PubMed ID: 30413829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of Long-Term Glycemic Remission After 2-Week Intensive Insulin Treatment in Newly Diagnosed Type 2 Diabetes.
    Wang H; Kuang J; Xu M; Gao Z; Li Q; Liu S; Zhang F; Yu Y; Liang Z; Zhao W; Yang G; Li L; Wang Y; Li G
    J Clin Endocrinol Metab; 2019 Jun; 104(6):2153-2162. PubMed ID: 30629195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Insulin and Metformin Versus Metformin Alone on β-Cell Function in Youth With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes.
    RISE Consortium
    Diabetes Care; 2018 Aug; 41(8):1717-1725. PubMed ID: 29941500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.